Smartwatch vs. Medical ECG: De-risking Cardiac AI Investments

Take AliveCor’s Kardia devices. They let someone record a medical-grade ECG on a small, portable device by capturing the heart’s actual electrical signals. The FDA has cleared them to detect specific arrhythmias like atrial fibrillation (AFib), bradycardia, and tachycardia because the device’s own algorithm analyzes the ECG waveform to give an interpretation of the heart’s electrical rhythm, providing real clinical insights. Lately, they’ve gone even further with the Kardia 12L ECG System, a handheld 12-lead powered by their KAI 12L AI engine. By January 2026, that AI got FDA clearance for a whopping 39 different cardiac determinations, we’re talking serious conditions like myocardial infarction and ischemia, plus rhythm modifiers like Atrial and Ventricular Bigeminy, and even axis morphology like Left or Right Axis Deviation. You can see the full list of what they’re authorized to diagnose in their AliveCor FDA clearances. Then there’s iRhythm’s approach with their Zio products, like the Zio XT and Zio AT patches. Instead of a spot check, these are wearable adhesive patches that a patient wears for days or even up to two weeks, continuously recording their ECG the entire time. This is how you catch transient arrhythmias that just won’t show up during a 10-second ECG in the clinic. The collected data is run through AI-backed analysis to spot and classify these events. Because these Zio patches are based on electrical ECG signals and have their own specific FDA diagnostic clearances, they give a clinician the full picture needed to actually make a diagnosis and create a treatment plan iRhythm FDA product information. Both of these examples show what real diagnostic-grade monitoring requires:

• Electrical Signal Capture: It has to measure the heart’s electrical activity directly.
• Specific FDA Clearance: The device needs a formal regulatory sign-off for diagnosing specific conditions.
• Clinical Validation: You need studies that prove its accuracy and reliability are on par with traditional hospital equipment.
• Actionable Clinical Output: It produces data a doctor can actually use to make a medical decision.
  

  The Gap: Why Your Smartwatch Isn’t a Diagnostic Tool (Unless Specifically Cleared)

Most of the confusion comes from people thinking ‘heart rate monitoring’ is all the same thing. It’s not. Your smartwatch uses a PPG sensor, that little green light which is great for telling you your heart rate while you’re resting or on a run, but it can’t definitively diagnose an arrhythmia on its own. That optical signal is fine for tracking general trends, but it doesn’t give you the detailed electrical waveform of an ECG, which is what you need for a real diagnosis. The algorithms in general wellness trackers also don’t go through the intense clinical validation and regulatory review that an FDA-cleared diagnostic device does. To get that clearance, a device has to prove with hard data that it can accurately classify specific heart problems with very high sensitivity and specificity, because when you’re making a medical call, a mistake can have serious outcomes. Yes, the cardiac AI monitoring market is moving fast, with better sensors and prediction methods coming out all the time. But the one thing that hasn’t changed is what makes a device useful for an actual clinical diagnosis: it must use an electrical ECG signal (not an optical PPG one) and it must have a specific regulatory clearance. So when you see marketing for a new gadget, you have to remember that a ‘heart rate monitor’ on a general fitness watch exists for a totally different reason, and is held to a completely different standard, than a true diagnostic ECG device.

Working through the Innovation Field

With cardiovascular AI moving so quickly, the line between a wellness gadget and a medical device does get blurry, especially as watch companies keep adding more ‘health’ features. But the foundation for clinical use is still the same: what’s the signal type and does it have regulatory clearance? For any tool to be a reliable cardiac diagnostic, it has to be capturing the heart’s electrical signal and it needs specific FDA clearances for whatever conditions it claims to find. So what good are all those fancy algorithms on a standard wearable without that foundation? They’re for your information and general wellness, not for a medical diagnosis. Knowing the difference lets you choose the right device and helps you understand when a weird reading on your fitness tracker is a sign to call a doctor, who can then pull out the real diagnostic-grade equipment if they need to. The future for cardiac AI is bright, we’ll see more precision and it’ll get into more hands, but the absolute need for proper clinical validation and regulatory oversight isn’t going anywhere. That’s the only way these tools earn a doctor’s trust and actually work.